Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2025
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2025
    • Abstract Submission Opens 31st March
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2025
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2025
    • Abstract Submission Opens 31st March
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA

Home

Resources

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 27/04/20 by Joseph Williams

Tackling antimicrobial resistance (AMR) in cancer patients at The Christie NHS Foundation Trust

View resources
Last reviewed: 27/04/20 by Mario Sobreira

Survey of profile and current practices of oncology pharmacists in Brazil

View resources
Last reviewed: 27/04/20 by Shirin Abadi

Strategies for the successful implementation of pharmacist prescribing initiative in oncology practice

View resources
Last reviewed: 27/04/20 by Siobhan Smith

Stability of cytarabine in an ambulatory infusion device

View resources
Last reviewed: 18/03/21 by Sarah Glewis

Sharing the care – hospital and community pharmacy partnership for the management of glucocorticoid-induced diabetes (GID)

Abstracts

View resources
Last reviewed: 27/04/20 by Fei-Fei Gao

Severe adverse events of PD-1 and PD-L1 inhibitors in ongoing clinical trials

View resources
Last reviewed: 27/04/20 by Himanshu Patel

Role of clinical pharmacists in reporting and monitoring of radiation related adverse events in cancer patients: a pilot study

View resources
Last reviewed: 27/04/20 by Louise J. McKee

Risk stratification of neutropenic sepsis: is the national early warning score (NEWS)) equivalent to multinational association for supportive care in cancer (MASCC) score?

View resources
Last reviewed: 27/04/20 by Karunrat Tewthanom

Risk factors influencing cardiotoxicity due to trastuzumab in breast cancer: a case-control study at King Chulalongkorn Memorial Hospital

View resources
Last reviewed: 27/04/20 by Mark Pearce

Review of the first year of a Pharmacist led Breast cancer oral therapies clinic. A joint working project between The Christie NHS Trust and Novartis

View resources
Last reviewed: 27/04/20 by Lenka Dolezalova

Removal of existing antineoplastic drug contamination from hospital surfaces – comparison of efficiency of different disinfectants

View resources
Last reviewed: 27/04/20 by Amritpal Atwal

Reducing intensity conditioning (RIC) protocol harmonisation in the UK

View resources

Filter for resources

  • Types

  • Tags

  • Reset

Previous 1 … 67 68 69 … 109 Next
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Conference 2024
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Twitter
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2025 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.